I Bergman

Summary

Affiliation: Children's Hospital of Pittsburgh
Country: USA

Publications

  1. ncbi request reprint Treatment of neoplastic meningeal xenografts by intraventricular administration of an antiganglioside monoclonal antibody, 3F8
    I Bergman
    Departments of Pediatrics and Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    Int J Cancer 82:538-48. 1999
  2. ncbi request reprint Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors
    I Bergman
    University of Pittsburgh Medical Center, Children s Hospital of Pittsburgh, PA, USA
    Cancer Immunol Immunother 49:259-66. 2000
  3. ncbi request reprint Treatment of meningeal breast cancer xenografts in the rat using an anti-p185/HER2 antibody
    I Bergman
    Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Clin Cancer Res 7:2050-6. 2001
  4. doi request reprint Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
    Y Gao
    Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Cancer Gene Ther 16:44-52. 2009
  5. pmc Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells
    Y Gao
    Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA 15224, USA
    Cancer Gene Ther 19:282-91. 2012
  6. ncbi request reprint Treatment of standard risk medulloblastoma with craniospinal irradiation, carboplatin, and vincristine
    I Bergman
    Department of Pediatrics, Children s Hospital of Pittsburgh, University of Pittsburgh Medical Center, PA, USA
    Med Pediatr Oncol 29:563-7. 1997

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Treatment of neoplastic meningeal xenografts by intraventricular administration of an antiganglioside monoclonal antibody, 3F8
    I Bergman
    Departments of Pediatrics and Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    Int J Cancer 82:538-48. 1999
    ..However, optimal activation and mobilization of neutrophils into the cerebrospinal fluid (CSF) and improved penetration of MAb to tumor sites remain critical variables...
  2. ncbi request reprint Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors
    I Bergman
    University of Pittsburgh Medical Center, Children s Hospital of Pittsburgh, PA, USA
    Cancer Immunol Immunother 49:259-66. 2000
    ..These data suggest that, for mouse IgG3, the rat may provide a more relevant rodent model than the mouse for testing the in vivo antitumor effects of monoclonal antibodies...
  3. ncbi request reprint Treatment of meningeal breast cancer xenografts in the rat using an anti-p185/HER2 antibody
    I Bergman
    Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Clin Cancer Res 7:2050-6. 2001
    ..Treatment with 4D5 did not result in outgrowth of cells lacking expression of the HER2/neu receptor. These results suggest that 4D5, administered regionally, may palliate LM metastases from HER2/neu-overexpressing breast carcinoma...
  4. doi request reprint Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
    Y Gao
    Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Cancer Gene Ther 16:44-52. 2009
    ..These studies demonstrate that targeted rrVSV combined with anti-CTLA4 MAb can eliminate established macroscopic tumor implants by eliciting an anti-tumor CD4 and CD8 T-cell immunologic response...
  5. pmc Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells
    Y Gao
    Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA 15224, USA
    Cancer Gene Ther 19:282-91. 2012
    ..Immunity elicited by viral therapy is independent of host major histocompatibility complex or knowledge of tumor antigens. Virus-induced tumor immunity could have great benefit in the prevention and treatment of tumor metastases...
  6. ncbi request reprint Treatment of standard risk medulloblastoma with craniospinal irradiation, carboplatin, and vincristine
    I Bergman
    Department of Pediatrics, Children s Hospital of Pittsburgh, University of Pittsburgh Medical Center, PA, USA
    Med Pediatr Oncol 29:563-7. 1997
    ....